[View original text]
On 8th of December 2022, AIDOT (CEO Jae-hoon Jeong) announced that On 6th of December, it has completed licensing and registration of Cerviray A.I., an artificial intelligence (AI)-based cervical cancer screening system, with the Ministry of Health of Vietnam.
In Vietnam, there are 2,223 deaths from cervical cancer each year, and 37.7 million women are said to be at risk of cervical cancer. However, as the cervical cancer screening rate is
only 6.5%, the need for efficient screening has been raised.
Since the beginning of this year, AIDOT has been collaborating with the Vietnamese Ministry of Health and local partners as well as product solution verification and clinical trials as
well as local health organizations for licensing and registration of Cerviray.
AIDOT said, “With the completion of license registration by the Ministry of Health of Vietnam, partners throughout Vietnam, including Ho Chi Minh and Hanoi, are proceeding with the
import of Cerviray. It is expected that at least 1,000 hospitals will be introduced Cerviray next year.” “In particular, the goal is to apply Vietnam’s national insurance fee in the first half
of next year, and it is progressing very smoothly until nowadays. We will do our best so that Cerviray can make a great contribution to the health of Vietnamese women.”
Rapportian / Reporter Hee-seok Jeong / 08th. Dec. 2022
Comments can be added by Member only